ReviewFrontiers in medicine2021

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.

Willis S Bowman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.